Forefront Analytics, LLC Pfizer Inc Transaction History

Forefront Analytics, LLC

$209 Million
Q2 2024

A detailed history of Forefront Analytics, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Forefront Analytics, LLC holds 15,049 shares of PFE stock, worth $394,885. This represents 0.2% of its overall portfolio holdings.

Number of Shares

15,049

Previous 12,860 17.02%

Holding current value

$394,885

Previous $356,000 18.26%

% of portfolio

0.2%

Previous 0.17%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $55,294 - $64,794	2,189 Added 17.02%	15,049 $421,000
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $65,527 - $75,246	2,531 Added 24.5%	12,860 $356,000
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $70,864 - $92,045	2,712 Added 35.6%	10,329 $297,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $3,786 - $4,426	-118 Reduced 1.53%	7,617 $252,000
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $59,995 - $69,413	1,661 Added 27.35%	7,735 $283,000
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $12,329 - $16,050	-313 Reduced 4.9%	6,074 $247,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $49,557 - $64,691	-1,187 Reduced 15.67%	6,387 $327,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $38,508 - $47,009	880 Added 13.15%	7,574 $329,000
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $13,912 - $16,495	299 Added 4.68%	6,694 $348,000
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $78,369 - $97,109	1,713 Added 36.59%	6,395 $336,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $193,460 - $286,772	4,682 New	4,682 $274,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.

Account

Forefront Analytics, LLC Pfizer Inc Transaction History